Fernando Pacheco

Endeavour Vision

Fernando Pacheco is an investment director at Endeavour Vision focused on medical technology, digital health, and diagnostics investments, with a particular focus on orthopaedics, robotics, general surgery, dental, ophthalmology, ENT and GI. In addition to Miach, he is currently a board observer at Virtual Incision Corporation and was a board observer of Sophia Genetics (NAS:SOPH) up until its IPO in July 2021. Previously, Fernando was an Engagement Manager at McKinsey & Company and an R&D engineer at Stryker Orthopaedics. He has a master’s degree in biomedical engineering from Imperial College London and ETH Zurich.